The need for active surveillance for low risk prostate cancer

2017-04-22

Additional Metadata
Keywords	active surveillance, adverse effects, low risk, MRI, overdiagnosis, overtreatment, Prostate cancer, PSA, screening
Persistent URL	doi.org/10.1080/14737140.2017.1319767, hdl.handle.net/1765/99434
Journal	Expert Review of Anticancer Therapy
Organisation	Erasmus MC: University Medical Center Rotterdam
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Drost, F.-J., & Roobol-Bouts, M. (2017). The need for active surveillance for low risk prostate cancer. Expert Review of Anticancer Therapy, 1–3. doi:10.1080/14737140.2017.1319767

Publication